Read More Pharma Industry News Why acute stress disorder may become the next major neuroscience opportunity for BXCL501 Could BXCL501 open a major new neuroscience market in acute stress disorder? Read what this means for BioXcel Therapeutics and investors. bySoujanya RaviApril 10, 2026